Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.

An array of analogues of the wasp toxin philanthotoxin-433, in which the asymmetric polyamine moiety was exchanged for spermine and the headgroup replaced with a variety of structurally diverse moieties, was prepared using parallel solid-phase synthesis approaches. In three analogues, the spermine moiety was extended with an amino acid tail, six compounds contained an N-acylated cyclohexylalanine, and four analogues were based on a novel diamino acid design with systematically changed spacer length between N-cyclohexylcarbonyl and N-phenylacetyl substituents. The analogues were studied using two-electrode voltage-clamp electrophysiology employing Xenopus laevis oocytes expressing GluA1(i) AMPA or GluN1/2A NMDA receptors. Several of the analogues showed significantly increased inhibition of the GluN1/2A NMDA receptor. Thus, an analogue containing N-(1-naphtyl)acetyl group showed an IC(50) value of 47 nM. For the diamino acid-based analogues, the optimal spacer length between two N-acyl groups was determined, resulting in an analogue with an IC(50) value of 106 nM.

[1]  K. McKeage Memantine , 2009, CNS drugs.

[2]  A. Kristensen,et al.  Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors. , 2009, Angewandte Chemie.

[3]  C. Parsons,et al.  Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors , 2009, Neuropharmacology.

[4]  R. Marum Update on the use of memantine in Alzheimer's disease. , 2009 .

[5]  D. Muñoz-Torrero Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. , 2008, Current medicinal chemistry.

[6]  Chris G. Parsons,et al.  Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse , 2007, Neuropharmacology.

[7]  S. Dravid,et al.  Subunit‐specific mechanisms and proton sensitivity of NMDA receptor channel block , 2007, The Journal of physiology.

[8]  M. Witt,et al.  Solid-phase synthesis of neuroactive spider–wasp hybrid toxin analogues using a backbone amide linker , 2007 .

[9]  L. Piazzi,et al.  Protolytic properties of polyamine wasp toxin analogues studied by 13C NMR spectroscopy , 2006, Magnetic resonance in chemistry : MRC.

[10]  T. Arendt,et al.  The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[11]  Henrik Zetterberg,et al.  Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.

[12]  M. Mayer Glutamate receptors at atomic resolution , 2006, Nature.

[13]  M. Witt,et al.  Tuning Wasp Toxin Structure for Nicotinic Receptor Antagonism: Cyclohexylalanine‐Containing Analogues as Potent and Voltage‐Dependent Blockers , 2006, ChemMedChem.

[14]  S. Lipton Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond , 2006, Nature Reviews Drug Discovery.

[15]  J. Growdon,et al.  Current pharmacotherapy for Alzheimer's disease. , 2006, Annual review of medicine.

[16]  J. Jaroszewski,et al.  N-Alkylation Reactions and Indirect Formation of Amino Functionalities in Solid-Phase Synthesis , 2005 .

[17]  M. Witt,et al.  On-Resin Carboxy Group Activation of ω-Amino Acids in Solid-Phase Synthesis­ of Philanthotoxin Analogues , 2005 .

[18]  S. Hansen,et al.  Side-chain-anchored N(alpha)-Fmoc-Tyr-OPfp for bidirectional solid-phase synthesis. , 2005, Organic letters.

[19]  K. Strømgaard,et al.  Polyamine toxins: development of selective ligands for ionotropic receptors. , 2005, Toxicon : official journal of the International Society on Toxinology.

[20]  P. Usherwood,et al.  The effects of conformational constraints and steric bulk in the amino acid moiety of philanthotoxins on AMPAR antagonism. , 2005, Journal of medicinal chemistry.

[21]  K. Strømgaard,et al.  Synthesis of polyamines and polyamine toxins. An improved alkylation procedure , 2004 .

[22]  M. Witt,et al.  Solid-phase synthesis of rigid acylpolyamines using temporary N-4,4'-dimethoxytrityl protection in the presence of trityl linkers. , 2004, The Journal of organic chemistry.

[23]  L. Wollmuth,et al.  Structure and gating of the glutamate receptor ion channel , 2004, Trends in Neurosciences.

[24]  M. Witt,et al.  Diols as Building Blocks in Solid-Phase Synthesis of Polyamine Toxins by Fukuyama-Mitsunobu Alkylation , 2004 .

[25]  S. Hansen,et al.  A sequential high-yielding large-scale solution-method for synthesis of philanthotoxin analogues. , 2003, European journal of medicinal chemistry.

[26]  P. Krogsgaard‐Larsen,et al.  Solid-phase synthesis of polyamine toxin analogues: potent and selective antagonists of Ca2+-permeable AMPA receptors. , 2002, Journal of medicinal chemistry.

[27]  T. Kan,et al.  Highly Versatile Synthesis of Polyamines by Ns-strategy on a Novel Trityl Chloride Resin , 2002 .

[28]  P. Usherwood,et al.  Solid-phase synthesis and biological evaluation of a combinatorial library of philanthotoxin analogues. , 2000, Journal of medicinal chemistry.

[29]  S. R. Chhabra,et al.  Solid-phase synthesis of polyamines using a Dde-linker: philanthotoxin-4.3.3 via an on-resin Mitsunobu reaction , 2000 .

[30]  P. Usherwood,et al.  Analogues of neuroactive polyamine wasp toxins that lack inner basic sites exhibit enhanced antagonism toward a muscle-type mammalian nicotinic acetylcholine receptor. , 1999, Journal of medicinal chemistry.

[31]  S. Walker,et al.  The Kinetic Characterization of Escherichia coli MurG Using Synthetic Substrate Analogues , 1999 .

[32]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[33]  G. Collingridge,et al.  Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells , 1996, British journal of pharmacology.

[34]  P. Krogsgaard‐Larsen,et al.  Neuroactive polyamine wasp toxins: nuclear magnetic resonance spectroscopic analysis of the protolytic properties of philanthotoxin-343. , 1996, Journal of medicinal chemistry.

[35]  M. Lebl,et al.  A Convenient Preparation of Monosubstituted N,N′-di(Boc)-Protected Guanidines. , 1994 .

[36]  P. Usherwood,et al.  Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors. , 1990, The Journal of pharmacology and experimental therapeutics.

[37]  A. Rosowsky,et al.  N.epsilon.-[[2-(Trimethylsilyl)ethoxy]carbonyl] derivatives of tri-L-lysine and tetra-L-lysine as potential intermediates in the block polymer synthesis of macromolecular drug conjugates , 1989 .

[38]  P. Usherwood,et al.  Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. , 1988, Proceedings of the National Academy of Sciences of the United States of America.